Abstract
In the past decade major advances have occurred in the clinical approaches to diagnosis and management of chronic nonallergic rhinitis. It is now clear that nonallergic forms of rhinitis are as common as allergic rhinitis. These forms can be clinically subcategorized for better therapeutic and prognostic purposes. Greater knowledge has been forthcoming concerning therapeutic agents used to treat other medical entities that may have secondary or side effects that directly impact on nasal disease. Old therapeutic agents have been improved and refined to make them more effective, longer acting, and with less toxic side effects. New agents that show significant promise for the more difficult-to-treat nasal diseases are on the horizon. The next 10 years should attract the basic scientist into the arena as these diseases come more and more under the scrutiny of the physicians best equipped to deal with them.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.